Soverini S, Bavaro L, De Benedittis C, et al. Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. Blood. 2020;135(8):534-541.

doi:10.1182/blood.2022015379

Soverini S, Bavaro L, De Benedittis C, et al. Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. Blood. 2020;135(8):534-541.

Blood (2022) 139 (10): 1601.

https://doi.org/10.1182/blood.2022015379

In the author affiliations on page 534, the affiliation for author Stefano Aldo Pileri (affiliation 29) should read “Istituto Europeo di Oncologia-IRCCS, Milan, Italy” instead of “Division of Haematopathology, European Institute of Oncology, Milan, Italy.” The error has been corrected in the online version of the article.

2022

Soverini S, Bavaro L, De Benedittis C, et al. Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. Blood. 2020;135(8):534-541.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology